Prospective investigation of drug resistance: an approach to understanding and optimizing the clinical benefit of targeted agents in Ewing sarcoma

Detalles Bibliográficos
Autor principal: Bailey, Kelly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
News
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324671/
https://www.ncbi.nlm.nih.gov/pubmed/30647860
http://dx.doi.org/10.18632/oncotarget.26465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324671/
https://www.ncbi.nlm.nih.gov/pubmed/30647860
http://dx.doi.org/10.18632/oncotarget.26465

Ejemplares similares